We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Partners Seek to Develop New Imagining Agents for Cardiovascular Disease Diagnosis

By MedImaging International staff writers
Posted on 09 Dec 2013
Print article
Partners in a recently signed research agreement will be developing new imaging agents for the noninvasive measurement of blood flow in the heart for the diagnosis of cardiovascular diseases–a sector worth of some two billion USD annually.

Hadasit (Jerusalem, Israel), the technology transfer company of the Hadassah Medical Organization (Jerusalem, Israel) announced the initiation of a three-year license and cooperation agreement with Synektik SA (Warsaw, Poland) to develop new imagining agents for use in PET/CT scans, which will enable the quantitative measurement of blood flow to the heart. The potential agents are expected to enable the clinician to determine the extent of damage resulting from a heart attack, and predict the degree of recovery after the heart attack or bypass surgery.

Research will be conducted at the Hadassah Medical Organization in Jerusalem in cooperation with Synektik's new research and development facility in Warsaw. Development funding of four million USD will be provided by Synektik, which will receive a worldwide license for any newly developed imaging agent and will spearhead further development, clinical trials registration, and commercialization.

Dr. Eyal Mishani, director of the cyclotron and radiochemistry unit of the Hadassah Medical Organization, said, "The funding would facilitate pre-clinical research and development stages and preparation for clinical trials which will be performed jointly with Synektik."

Related Links:

Hadasit
Hadassah Medical Organization
Synektik SA


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Portable X-Ray Unit
AJEX240H
New
X-Ray Detector
FDR-D-EVO III
Dose Area Product Meter
VacuDAP

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.